Eli Lilly (LLY) says it's diagnostic radiopharmaceutical Amyvid has received marketing...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

Eli Lilly (LLY) says it's diagnostic radiopharmaceutical Amyvid has received marketing authorization from the European Commission for Positron Emission Tomography imaging of beta-amyloid neuritic plaque density in the brains of adult patients with Alzheimer's Disease and other forms of cognitive impairment.